Dapagain-M Tablet 10mg/500mg 15s
₹99.99
Estimate Delivery by -

DAPAGAIN-M TABLET 10 mg/500 mg
Pack Size: 15 Tablets
COMPOSITION
Each tablet contains:
Dapagliflozin 10 mg
Metformin Hydrochloride 500 mg
THERAPEUTIC CATEGORY
Anti-diabetic medicine (Oral hypoglycemic agent)
INDICATIONS
Used for the treatment of Type 2 Diabetes Mellitus in adults.
Helps control high blood sugar levels when diet and exercise alone are not sufficient.
May be prescribed alone or along with other anti-diabetic medicines.
MECHANISM OF ACTION
Dapagliflozin:
Works by removing excess glucose from the body through urine by acting on the kidneys.
Metformin:
Reduces glucose production in the liver.
Improves insulin sensitivity.
Helps the body utilize insulin more effectively.
DOSAGE AND ADMINISTRATION
Take exactly as prescribed by the doctor.
Usually taken once or twice daily with meals.
Swallow the tablet whole with water.
Do not crush or chew.
Take at the same time every day for best results.
MISSED DOSE
Take the missed dose as soon as remembered.
Skip if it is almost time for the next dose.
Do not take a double dose.
COMMON SIDE EFFECTS
Nausea
Vomiting
Diarrhea
Stomach pain
Increased urination
Headache
Weakness
SERIOUS SIDE EFFECTS (Seek immediate medical attention)
Signs of low blood sugar (sweating, trembling, dizziness)
Severe abdominal pain
Persistent vomiting
Shortness of breath
Unusual tiredness
Signs of urinary or genital infection
PRECAUTIONS
Inform the doctor if you have kidney, liver, or heart problems.
Avoid excessive alcohol intake.
Maintain proper hydration.
Regular blood sugar monitoring is required.
Inform your doctor about all other medicines being taken.
USE IN SPECIAL POPULATIONS
Pregnancy: Use only if prescribed by a doctor.
Breastfeeding: Consult doctor before use.
Elderly patients: Dose adjustment may be required based on kidney function.
STORAGE
Store in a cool and dry place.
Keep away from direct sunlight and moisture.
Keep out of reach of children.
NOTE
This medicine should be taken under medical supervision. Regular monitoring of blood glucose and kidney function is recommended during treatment.

